Sep 18, 2020 - Economy

U.S. nutritional supplements retailer takes first step to sell to China’s Harbin Pharma

Dan Primack

Illustration of a chess piece with a gavel top — Illustration: Sarah Grillo/Axios

GNC Holdings, the Pittsburgh-based nutritional supplements retailer, received bankruptcy court approval to sell itself to China’s Harbin Pharma for $770 million, although the deal still faces U.S. political pressures over how GNC customer data is protected.

Why it matters: It's a reminder that the U.S.-China merger mess goes well beyond smartphone apps, with Sen. Marco Rubio asking for a CFIUS review.

Details: Harbin still needs Canadian bankruptcy court approval for the deal, which would see it assume around 1,400 storefronts (some of which it would close). For 2019, GNC reported a $35 million net loss on over $2 billion in revenue.

The bottom line: "GNC traces its roots to 1935 when David Shakarian opened a health-food shop selling yogurt and sandwiches in Pittsburgh. The chain rode a wave of interest in nutrition, eventually expanding to over 9,000 outlets. It’s using the bankruptcy process to get out of and renegotiate expensive leases," Bloomberg's Katherine Doherty reports.

Add Axios on Google

U.S. nutritional supplements retailer takes first step to sell to China’s Harbin Pharma

What to read next